[ET Net News Agency, 2 July 2021] Luye Pharma Group Ltd. (02186) said the company has
submitted a proposal to the Stock Exchange to effect the spin-off and separate listing of
Shandong Boan Biotechnology Co., Ltd. (Boan Biotech).
Boan Biotech is a fully integrated biopharmaceutical company established in mainland
China. It specializes in therapeutic antibody development, manufacturing and
commercialization with a focus on oncology, autoimmune, pain, and endocrine diseases. (RC)